According to the latest research conducted in 2025, the global hepatitis B treatment market size is estimated at USD 5.6 billion in 2024. The market is expected to grow at a robust CAGR of 4.8% from 2025 to 2033, reaching a projected value of USD 8.5 billion by 2033. This growth is primarily driven by the increasing prevalence of hepatitis B infections worldwide, significant advancements in antiviral therapies, and heightened awareness of early diagnosis and treatment options. https://growthmarketreports.com/report/hepatitis-b-treatment-market-global-industry-analysis